EMPLOYMENT AGREEMENTEmployment Agreement • May 15th, 2024 • Aileron Therapeutics, Inc. • Pharmaceutical preparations • Texas
This Employment Agreement (this “Agreement’) is made and entered into as of December 13, 2018 (the “Effective Date”) by and between Lung Therapeutics, Inc. (the “Company”), and Charles T. Garner, an individual (“Executive”).
LUNG THERAPEUTICS, INC.Employment Agreement • May 15th, 2024 • Aileron Therapeutics, Inc. • Pharmaceutical preparations
As you know, Lung Therapeutics, Inc. (the “Company”) previously entered into an Employment Agreement with you dated December 13, 2018 (the “Agreement”). The Company desires to modify the Agreement effective October 30, 2023, as follows:
Re: Retention AgreementRetention Agreement • May 15th, 2024 • Aileron Therapeutics, Inc. • Pharmaceutical preparations
This letter shall not be construed as an agreement, either express or implied, to employ you for any stated term, and shall in no way alter the Company’s policy of employment at-will. This letter shall supplement the terms and conditions of your employment with the Company and shall not supersede any prior written agreement between you and the Company, including the Employment Agreement.
